SHILPAMED943.00

Shilpa Medicare Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersNATCOPHARMSPARCSTARRUBICONSUPRIYATHYROCAREVIYASHPARKHOSPSMcap ₹18,445 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations1,151.61,286.41,538.91,682.5
Other Income8.223.29.87.4
Total Income1,159.81,309.61,548.71,689.8
Expenses
+ Cost of Materials Consumed424.3350.3471.0500.5
+ Purchases of Stock-in-Trade18.022.525.629.9
+ Changes in Inventories-34.837.6-36.2-14.5
+ Employee Benefit Expense281.5292.7334.9352.8
+ Finance Costs91.875.558.852.1
+ Depreciation & Amortisation107.9113.0119.7126.0
+ Other Expenses218.1266.3308.9335.2
Total Expenses1,106.81,157.91,282.71,382.0
EBITDA244.5317.0434.7478.6
EBIT136.6204.1315.0352.5
Profit
PBT before Exceptional Items53.0151.7266.0307.8
+ Exceptional Items6.1-28.129.330.5
Pretax Income59.1123.6295.3338.3
+ Current Tax45.373.346.761.7
+ Deferred Tax-22.9-29.35.3-15.2
Tax Expense22.444.052.046.5
+ Share of Associates & JVs-4.9-1.30.05.5
Net Income31.978.3243.3297.3
+ Net Income — Continuing Ops36.779.6243.3291.8
+ Other Comprehensive Income-2.4-2.30.04.2
Total Comprehensive Income29.576.0243.3301.5
Minority Interest0.0-0.0
Per Share
Basic EPS3.678.0412.4415.28
Diluted EPS3.678.0412.4415.28
Other Comprehensive Income — detail
+ Other Comprehensive Income-2.3
+ Items NOT to be Reclassified to P&L-3.5-2.3
+ Tax on Items NOT to be Reclassified — alt tag-1.1
Per Share — as-filed variants
Basic EPS — Continuing Operations3.678.0412.4415.28
Diluted EPS — Continuing Operations3.678.0412.4415.28
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit744.0876.01,078.51,166.5
Gross Margin %64.6168.1070.0869.33
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)53.0151.7266.0307.8
− Exceptional Items (reconciliation)6.1-28.129.330.5
Net Income Adj (tax-effected)28.196.4219.2271.0
EPS Adj3.239.9011.2113.93
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value1.001.001.001,956.00
Paid Up Equity Capital8.79.819.619.6
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.